Effects on the improvement of blood glucose and changes in body composition of oral anti-diabetic drug SGLT2 inhibitor.~ Relevance to the compliance of the diet therapy for diabetes~
Not Applicable
- Conditions
- Diabetes
- Registration Number
- JPRN-UMIN000022738
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method